Tissue Repository for Studies of Myasthenia Gravis
NCT02902536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6
Last updated 2019-09-13
Summary
This is a study during which the investigators collect plasma and cells from patients with myasthenia gravis for the purpose of finding new antibodies.
Conditions
Interventions
- OTHER
-
No interventions
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2019-08-31
- Completion
- 2019-08-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
NCT02473952 ·Status: COMPLETED ·Phase: PHASE2
-
The EXPLORE MG Registry for Myasthenia Gravis
NCT03792659 ·Status: RECRUITING
-
Congenital Athymia Patient Registry
NCT05329935 ·Status: RECRUITING
-
A Prospective Cohort Study Of Myasthenia Gravis
NCT04674605 ·Status: UNKNOWN
-
Study of Telitacicept in Generalized Myasthenia Gravis
NCT05737160 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
NCT06704269 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
NCT02110706 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
NCT07250750 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
NCT03052751 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolate Mofetil in Myasthenia Gravis
NCT00285350 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
NCT03772587 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis
NCT04302103 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
NCT07039916 ·Status: RECRUITING ·Phase: PHASE3
-
Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis
NCT01828294 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
NCT06298552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984 ·Status: RECRUITING
-
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
NCT05332587 ·Status: UNKNOWN ·Phase: PHASE3
-
Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
NCT03597373 ·Status: UNKNOWN
-
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
NCT05214612 ·Status: RECRUITING
-
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920 ·Status: RECRUITING ·Phase: PHASE3
-
Immune Profiles in Myasthenia Gravis
NCT05095103 ·Status: UNKNOWN
-
Myasthenia Gravis Foundation of America Global MG Patient Registry
NCT06617741 ·Status: RECRUITING
-
A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis
NCT00533091 ·Status: COMPLETED ·Phase: PHASE1
-
Acupuncture in Myasthenia Gravis (AcuMG)
NCT05230082 ·Status: COMPLETED ·Phase: NA